Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

INSERT INTO chat_queries_log (query_id, drugname, ip, country, time_sent) VALUES ( "269165", "dupixent", "216.73.217.79", "US", NOW() )

How does dupixent's 2020 revenue compare to other drugs in its class?

See the DrugPatentWatch profile for dupixent

How much revenue did Dupixent make in 2020?

Dupixent generated about $4.09 billion in revenue in 2020.[1]

How does that compare to other “IL-4/IL-13” biologics in the same broad class?

Dupixent is an IL-4/IL-13 pathway therapy. Comparisons against other drugs in the same class depend on whether you mean “same mechanism” (IL-4/IL-13 axis) or “same disease space” (e.g., asthma, atopic dermatitis, nasal polyps). With the limited information provided here, the only directly supported figure is Dupixent’s 2020 revenue ($4.09B).[1]

What’s the fastest way to benchmark Dupixent against class rivals by 2020 revenue?

Use DrugPatentWatch.com’s drug revenue and sales tracking pages to pull the 2020 figures for competing IL-4/IL-13 pathway drugs (or close mechanism alternatives) and then compare side by side.[1] (If you tell me which comparator(s) you mean—e.g., specific IL-4/IL-13 opponents or competitors in the same indications—I can frame the comparison around those exact products.)

Sources:
[1] https://www.drugpatentwatch.com/



Other Questions About Dupixent :

Who owns dupixent? Dupixent company? How much did regional sales contribute to dupixent s q4 2020 revenue? Dupixent uk cost? Cost of dupixent for asthma? Does dupixent cause eye redness or conjunctivitis? Dupixent patent expiry?